Navigation Links
Ohio State University Medical Center to Test Efficacy of Hyperbaric Oxygen Medicine on Stroke Victims
Date:5/20/2008

ANAHEIM, Calif., May 20 /PRNewswire/ -- With the financial support of Sechrist Industries, Inc., The Center for Minimally Invasive Surgery (CMIS) at the Ohio State University Medical Center has begun testing the efficacy of hyperbaric oxygen medicine on experimental stroke models. CMIS is a multidisciplinary center dedicated to excellence in patient care, clinical training, research and outcomes studies pertaining to the techniques and technology of minimally invasive surgery.

Currently utilized for the treatment of chronic, non-healing wounds, carbon monoxide poisoning, crush injuries as well as other indications, the use of hyperbaric medicine for stroke victims is at the forefront of hyperbaric research. Hyperbaric oxygen therapy is the treatment of the entire body with 100-percent oxygen at greater than normal atmospheric pressures. Hyperbaric medicine greatly increases oxygen concentration in all body tissues, even with reduced or blocked blood flow, stimulates the growth of new blood vessels to locations with reduced circulation (improving blood flow to areas with arterial blockage) and causes a rebound arterial dilation after treatment, resulting in an increased blood vessel diameter greater than when therapy began, thus improving blood flow to compromised organs. The CMIS team is hopeful that these benefits of hyperbaric oxygen treatments will positively affect stroke patients.

"Ohio State University Medical Center is one of the finest health care institutions in the country," stated Jack Rollins, President and CEO of Sechrist Industries, Inc. "As the world leader in hyperbaric oxygen technology, we feel that it is important to join forces with CMIS to support research in the field of hyperbaric medicine."

"We believe that there is a window of opportunity to treat stroke related injury of the brain using hyperbaric oxygen. The challenge lies in accurately defining the perimeters of that window," says Chandan Sen, Director of the C
'/>"/>

SOURCE Sechrist Industries, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Data re-analysis shows drug finasteride reduces risk for most prostate cancers
2. Forty-Two Free Clinics Across State Share $1 Million in Grants From Blue Cross Blue Shield of Michigan
3. Pennsylvania Attorney General Corbett Announces a Multi-state, $58 Million Settlement With Merck Over Deceptive Advertising Concerning the Safety of Vioxx
4. Mapping of prostate cancer genes opens the door to new treatments
5. Radiation for Prostate Cancer Raises Risk of Other Cancers
6. MR imaging accurately determines prostate cancer treatment failure
7. ACS Expands State Medicaid Presence with $156 Million Tennessee Contract
8. New data show benefit of finasteride in preventing prostate cancer
9. Prostate Cancer Vaccine Looks Promising in Early Trial
10. AUDIO from Medialink, Oral Health America & Philips Sonicare: National Smile Month - Giving Americans Something to Smile About Survey Reveals State of Americans Oral Health
11. Paramedics, EMTs in Oregon, Washington State Ratify First-Ever Teamsters Contract
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/22/2014)... Rockville Centre, NY (PRWEB) September 22, 2014 ... Goodwin, before whom all of the federal mesh ... Boston Scientific Corp. have been consolidated for pretrial ... re: Boston Scientific Corp. Pelvic Repair System Products ... Southern District of West Virginia; Case no. 2:12-md-02326)—requiring ...
(Date:9/22/2014)... News) -- Teens and young adults at risk for ... help prevent risky sexual behaviors, according to new recommendations ... year, about 20 million new sexually transmitted infections such ... About half involve people between 15 and 24 years ... new report, published Sept. 22 in Annals of ...
(Date:9/22/2014)... September 22, 2014 Manhattan residents who ... side of the hip , which could be bursitis ... This treatment is now offered at New York Dynamic ... called trochanteric bursitis, occurs when the trochanteric bursa becomes ... in the hip, between the iliotibial band and the ...
(Date:9/22/2014)... to 40 percent of patients undergoing breast cancer surgery ... all the cancerous tissue in the initial operation. However, ... tested a tool they developed that will help surgeons ... decreasing the chances for repeat operations. ... September 22, 2014 in the Proceedings of the ...
(Date:9/22/2014)... Hamilton, ON (September 22, 2014) South Asians living ... and double the rate of diabetes compared with while ... was published today in the Canadian Medical Association ... http://www.cmajopen.ca/content/2/3/E183.full , One of the fastest-growing ethnic ... million South Asian people living in Canada, comprising about ...
Breaking Medicine News(10 mins):Health News:Federal Court Sets Trial Date for Boston Scientific Vaginal Mesh Cases in Florida, the Rottenstein Law Group LLP Reports 2Health News:Behavioral Counseling Urged for Teens, Young Adults at Risk for STDs 2Health News:Behavioral Counseling Urged for Teens, Young Adults at Risk for STDs 3Health News:DNR Clinic Offers Hip Bursitis Treatment in Manhattan 2Health News:DNR Clinic Offers Hip Bursitis Treatment in Manhattan 3Health News:The fine line between breast cancer and normal tissues 2Health News:Higher risk of heart disease for South Asians in Canada 2
... 19 /PRNewswire-FirstCall/ - Notification of Year End,2007 Earnings Webcast ... (TSX: RBM) Year End 2007 Earnings Webcast and ... To listen to this Webcast and Conference Call ... To participate in the live conference call please dial ...
... Using the Canadian Light Source synchrotron, an international team led ... detailed structure of the enzyme the Norwalk virus uses to ... itself. The information is crucial to developing drugs that could ... viruses. , The Norwalk virus uses the enzyme, RNA ...
... (OTC,Bulletin Board: RXEI), a developer, manufacturer, and marketer of ... its,2007 year-end financial results in a conference call on ... Company will release its 2007 year-end financial results after ... call will be,RxElite CEO Jonathan Houssian, COO Earl E. ...
... ST. LOUIS, March 18 Sigma-Aldrich (Nasdaq:,SIAL) announced ... its $300 million,revolving credit facility established in December ... feature. Under the revised $450 million,revolving credit facility, ... and,$420 million will mature on December 11, 2012. ...
... The Pharmaceutical Care,Management Association (PCMA) issued the ... that are being,debated in Congress:, "PCMA ... drug,therapies is an important tool in promoting ... way with Pharmacy & Therapeutics,(P&T) committees and ...
... mental acuity may actually improve , , TUESDAY, March 18 ... treatment, head-and-neck cancer patients experience decreases in their physical ... quality of life, says a U.S. study. , ... that head and neck cancer treatment such as feeding ...
Cached Medicine News:Health News:Scientists see Norwalk virus' Achilles heel 2Health News:RxElite Inc. Fourth Quarter and Year-End 2007 Earnings Release and Conference Call Notice 2Health News:Head and Neck Cancer Outcomes a Mixed Bag 2
(Date:9/22/2014)... Sept. 22, 2014 Avanir Pharmaceuticals, Inc. (NASDAQ: ... offering to sell $200 million of its common stock ... Securities and BofA Merrill Lynch are acting as joint ... underwriters a 30-day option to purchase additional shares of ... sold in the offering are being sold by Avanir.  ...
(Date:9/22/2014)... September 22, 2014 ... the addition of the  "Global Remotes Market ...      (Logo: http://photos.prnewswire.com/prnh/20130307/600769) Remotes/remote controls ... operate electronic gadgets such as smart TVs, ... a short line-of-sight distance. Remote controls are ...
(Date:9/22/2014)... 2014 Research and Markets  has announced ... 2014-2018" report to their offering. ... comprehensive and up-to-date publication available covering the neurotechnology industry. ... markets, competitors, and growth rates in four key segments ... 2018. It forecasts the number of systems to be ...
Breaking Medicine Technology:Avanir Pharmaceuticals Announces Proposed Public Offering of Common Stock 2Avanir Pharmaceuticals Announces Proposed Public Offering of Common Stock 3Global Remotes Market 2014-2018 2Global Remotes Market 2014-2018 3The Market for Neurotechnology: 2014-2018 2
... Clean Holdings, Inc. (Nasdaq: UCTT ), a leading ... equipment, flat panel, solar, and medical device industries, today announced ... Officer. Ultra Clean will immediately begin a search to identify ... "We thank David for his service to Ultra Clean and ...
... (NYSE: WST ) today announced that its Board ... share in the Company,s quarterly cash dividend, to $0.17 per ... increase is the eighteenth consecutive annual increase in the Company,s ... November 3, 2010 to shareholders of record on October 20, ...
Cached Medicine Technology:
... is a complete practice and business ... optometrists, opticians and ophthalmologists- It is ... seeking a graphically rich and intuitive ... of solid features and functionality- The ...
... 70 hematology system delivers a ... Designed for speed and accuracy, ... cost-effectiveness with impressive productivity. The ... on its own or twinned ...
The SE-9500 automated hematology analyzerprovides accurate and precise CBC result including a fully automated WBC 5-part differential, and comprehensive test results for enhanced screening ability....
The SE-9000 automated hematology analyzer provides accurate and precise CBC result including a fully automated WBC 5-part differential, and comprehensive test results for enhanced screening ability....
Medicine Products: